Adherence to national guidelines for colorectal cancer screening in Israel: Comprehensive multi-year assessment based on electronic medical records
- PMID: 32356670
- DOI: 10.1177/0969141320919152
Adherence to national guidelines for colorectal cancer screening in Israel: Comprehensive multi-year assessment based on electronic medical records
Abstract
Objectives: To assess time trends in colorectal cancer screening uptake, time-to-colonoscopy completion following a positive fecal occult blood test and associated patient factors, and the extent and predictors of longitudinal screening adherence in Israel.
Setting: Nation-wide population-based study using data collected from four health maintenance organizations for the Quality Indicators in Community Healthcare Program.
Methods: Screening uptake for the eligible population (aged 50-74) was recorded 2003-2018 using aggregate data. For a subcohort (2008-2012, N = 1,342,617), time-to-colonoscopy following a positive fecal occult blood test and longitudinal adherence to screening guidelines were measured using individual-level data, and associated factors assessed in multivariate models.
Results: The annual proportion screened rose for both sexes from 11 to 65%, increasing five-fold for age group 60-74 and >six-fold for 50-59 year olds, respectively. From 2008 to 2012, 67,314 adults had a positive fecal occult blood test, of whom 71% eventually performed a colonoscopy after a median interval of 122 (95% confidence interval 110.2-113.7) days. Factors associated with time-to-colonoscopy included age, socioeconomic status, and comorbidities. Only 25.5% of the population demonstrated full longitudinal screening adherence, mainly attributable to colonoscopy in the past 10 years rather than annual fecal occult blood test performance (83% versus 17%, respectively). Smoking, diabetes, lower socioeconomic status, cardiovascular disease, and hypertension were associated with decreased adherence. Performance of other cancer screening tests and frequent primary care visits were strongly associated with adherence.
Conclusions: Despite substantial improvement in colorectal cancer screening uptake on a population level, individual-level data uncovered gaps in colonoscopy completion after a positive fecal occult blood test and in longitudinal adherence to screening, which should be addressed using focused interventions.
Keywords: population-based; screening, colorectal cancer, longitudinal adherence, colonoscopy completion.
Similar articles
-
Is the patient activation measure associated with adherence to colonoscopy after a positive fecal occult blood test result?Isr J Health Policy Res. 2018 Dec 21;7(1):74. doi: 10.1186/s13584-018-0270-8. Isr J Health Policy Res. 2018. PMID: 30577883 Free PMC article. Clinical Trial.
-
Barriers to completing colonoscopy after a positive fecal occult blood test.Isr J Health Policy Res. 2021 Feb 11;10(1):11. doi: 10.1186/s13584-021-00444-2. Isr J Health Policy Res. 2021. PMID: 33573698 Free PMC article.
-
Longitudinal Adherence to Immunochemical Fecal Occult Blood Testing vs Guaiac-based FOBT in an Organized Colorectal Cancer Screening Program.Cancer Prev Res (Phila). 2019 May;12(5):327-334. doi: 10.1158/1940-6207.CAPR-18-0091. Epub 2019 Mar 19. Cancer Prev Res (Phila). 2019. PMID: 30890542
-
Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines.Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):108-13. doi: 10.1158/1055-9965.EPI-05-0198. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16434595 Review.
-
Colorectal Cancer Screening: Is Colonoscopy the Best Option?Med Clin North Am. 2019 Jan;103(1):111-123. doi: 10.1016/j.mcna.2018.08.010. Epub 2018 Nov 1. Med Clin North Am. 2019. PMID: 30466668 Review.
Cited by
-
Socioeconomic Disparity Trends in Cancer Screening Among Women After Introduction of National Quality Indicators.Ann Fam Med. 2021 Sep-Oct;19(5):396-404. doi: 10.1370/afm.2715. Ann Fam Med. 2021. PMID: 34546946 Free PMC article.
-
Factors associated with positive predictive value of preliminary screening in a two-step screening strategy for colorectal neoplasms in China.Discov Oncol. 2022 Jan 8;13(1):4. doi: 10.1007/s12672-022-00463-8. Discov Oncol. 2022. PMID: 35201502 Free PMC article.
-
Global colorectal cancer screening programs and coverage rate estimation: an evidence synthesis.J Transl Med. 2025 Jul 22;23(1):811. doi: 10.1186/s12967-025-06887-4. J Transl Med. 2025. PMID: 40696392 Free PMC article.
-
Current and future colorectal cancer screening strategies.Nat Rev Gastroenterol Hepatol. 2022 Aug;19(8):521-531. doi: 10.1038/s41575-022-00612-y. Epub 2022 May 3. Nat Rev Gastroenterol Hepatol. 2022. PMID: 35505243 Free PMC article. Review.
-
Potential global loss of life expected due to COVID-19 disruptions to organised colorectal cancer screening.EClinicalMedicine. 2023 Jul 20;62:102081. doi: 10.1016/j.eclinm.2023.102081. eCollection 2023 Aug. EClinicalMedicine. 2023. PMID: 37538541 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous